Founded in 2017, Chongqing Medleader Bio-Pharm Co., Ltd. is a comprehensive Contract Research Organization focused on pre-clinical and clinical research services regarding chemical drugs, preventive and therapeutic biological products and medical devices.

With the state-of-the-art facilities and strong expertise in advanced technologies, we have successfully set up four comprehensive platforms including Pharmaceutical Research, Center for Drug Safety Evaluation and Research, Clinical Medicine and Biotechnology. Involved in various phases of drug research and development, Medleader dedicates to shorten the cycle of drug R&D and reduce the cost of research and development through efficient research and development services, and to provide the whole-chain CRO service from GLP to GCP for pharmaceutical research and development institutions and enterprises.

Focusing on R&D management and having established a R&D team with international and domestic high-end scientific personnel, Medleader regards technological innovation and standardized project management as the foundation and source of development. We own the professional team with pharmaceutical, medical, chemistry, biology, and statistics backgrounds and the core management team experienced in biomedical industry.

The Medleader U.S. Center was established in New York in early 2019 to provide FDA new drug registration, clinical trials and technical consulting services.